Perception of Unpleasant Sensations During Study Procedures in ALS Patients
NCT06325865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2025-11-18
Summary
Diagnosis of Amyotrophic Lateral Sclerosis (ALS) is considered a traumatic life event for both the patient and their next-of-kin/carers, due to the lack of treatment. Clinical Trials can offer pioneering treatment to reduce the impact of the disease and improve future treatments worldwide. Research protocols may involve routine diagnostic and/or therapeutic procedures which the patients may be already aware of and, therefore, expecting specific sensations. These could compromise participation or drop-out rate. Despite everything, participation in a clinical trial can guarantee continuity of care also thanks to the execution of these same procedures, through preferential access compared to other patients.
Aim of this study is to investigate the unpleasant sensations perceived by ALS patients during procedures in clinical trials. Analysing what type of pain/discomfort frightens patients during diagnostic and/or therapeutic procedures, including the different methods of administration of the study drug. Provide data to implement effective therapy and offer constant patients support throughout ALS specific and needed procedures. Evaluate if this support could influence adherence rate of ALS patients to conduct clinical trials as required. Provide information for future studies to create an ALS Clinical Trials multiple-retention-factors adherence scale. Create and implement an ALS-specific pain scale accounting for its impact on daily activities, aiding an interdisciplinary approach of pain management. Identify the best pain management strategies and compliance techniques to address ALS, not merely in clinical trials. Provide the best individualized care for ALS patients improving their quality of life and mental state.
This is a descriptive phenomenological study and data will be analyzed according to Sundler's method. Based on the experience of the researchers and the recommendations proposed by Sandelowski, a total of 20 interviews are estimated in order to reach the theoretical saturation per category of reference. Data collection will be carried out through in-depth semi-structured interviews recorded (13 open-ended questions after the execution of the procedures).
Conditions
Interventions
- OTHER
-
Interview
Interview with ALS patient in which the experiences of unpleasant sensations or pain during study procedures are assessed in a qualitative manner.
Sponsors & Collaborators
-
Istituto Auxologico Italiano
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-19
- Primary Completion
- 2024-01-24
- Completion
- 2024-01-24
Countries
- Italy
Study Locations
More Related Trials
-
At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis
NCT07006571 ·Status: RECRUITING ·Phase: NA
-
Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)
NCT01640067 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
NCT06608004 ·Status: RECRUITING
-
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT04849065 ·Status: UNKNOWN ·Phase: PHASE2
-
RT001 in Amyotrophic Lateral Sclerosis
NCT04762589 ·Status: COMPLETED ·Phase: PHASE2
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China
NCT04328675 ·Status: UNKNOWN
-
Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01933321 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS
NCT06917924 ·Status: RECRUITING
-
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
NCT06318598 ·Status: RECRUITING
-
Neuromuscular Magnetic Stimulation in ALS Patients
NCT03618966 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial Ceftriaxone in Subjects With ALS
NCT00349622 ·Status: COMPLETED ·Phase: PHASE3
-
potentiALS - Quality of Life Among Patients With Amyotrophic Lateral Sclerosis
NCT06441448 ·Status: RECRUITING
-
Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
NCT02383654 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS
NCT05747937 ·Status: RECRUITING ·Phase: NA
-
Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
NCT02152449 ·Status: COMPLETED ·Phase: NA
-
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329 ·Status: RECRUITING
-
Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry
NCT07143656 ·Status: ACTIVE_NOT_RECRUITING
-
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
NCT04454892 ·Status: RECRUITING
-
Biological Treatment of Amyotrophic Lateral Sclerosis
NCT02193893 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trial of Ultra-high Dose Methylcobalamin for ALS
NCT03548311 ·Status: COMPLETED ·Phase: PHASE3
-
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)
NCT06910384 ·Status: TERMINATED ·Phase: PHASE2